COVID-19 studies are our top priority. For all other studies, we recommend commencing the registration process concurrently with your ethics submission and allowing at least 8 weeks for registration to be completed from date of first submission as we are experiencing 4 week turn-around time in review of submissions and resubmissions. We currently do not have the capacity to expedite reviews.

Note also there are additional delays to review of updates. We appreciate your patience.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial registered on ANZCTR

Registration number
Ethics application status
Date submitted
Date registered
Date last updated
Type of registration
Prospectively registered

Titles & IDs
Public title
Efficacy of an oral herbal compound in treatment of acute anal fissure
Scientific title
In patients with acute anal fissure, treatment with oral herbal remedies in comparison to placebo will alleviate signs and symptoms (pain, itching, bleeding) of patients.
Secondary ID [1] 253607 0
Universal Trial Number (UTN)
Trial acronym
Linked study record

Health condition
Health condition(s) or problem(s) studied:
Acute anal fissure 261168 0
Condition category
Condition code
Alternative and Complementary Medicine 259322 259322 0 0
Herbal remedies

Study type
Description of intervention(s) / exposure
Oral administration of one capsule 40 mg containing herbal compounds (mixture of salep and Ginger) three times a day (before breakfast, lunch and dinner) for 6 days
Intervention code [1] 258031 0
Treatment: Other
Comparator / control treatment
Placebo capsules (made up of starch) with the same dose and route of administration
Control group

Primary outcome [1] 262126 0
Alleviation of pain and itching assessing by questionnaires containing questions about presence and severity of signs and symptoms correlated with fissure.
Timepoint [1] 262126 0
3 days after initiation of treatment
Secondary outcome [1] 273207 0
anatomical improvement of anal fissure and recovery of bleeding assessing by questionnaires and physical exam.containing questions about presence and severity of signs and symptoms correlated with fissure.
Timepoint [1] 273207 0
6 days after initiation of treatment

Key inclusion criteria
Patients with proven anal fissure with 4 weeks or lower from initiation of the disease.
Minimum age
0 Years
Maximum age
No limit
Both males and females
Can healthy volunteers participate?
Key exclusion criteria
1. Pregnant women
2. Patients with uncontrolled acute or systemic illnesses
3. Inflammatory bowl disease
4. Chronic fissure
5. Use of psychiatric medications due to acute psychiatric illness

Study design
Purpose of the study
Allocation to intervention
Randomised controlled trial
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Masking / blinding
Who is / are masked / blinded?

Intervention assignment
Other design features
Type of endpoint(s)
Statistical methods / analysis

Recruitment status
Not yet recruiting
Date of first participant enrolment
Date of last participant enrolment
Date of last data collection
Sample size
Accrual to date
Recruitment outside Australia
Country [1] 3197 0
Iran, Islamic Republic Of
State/province [1] 3197 0

Funding & Sponsors
Funding source category [1] 258503 0
Name [1] 258503 0
Shiraz University of medical science-
Address [1] 258503 0
7th floor, Deputy of research and technology, Shiraz University of medical sciences, Zand Ave, Shiraz, Fars province, Iran,
Country [1] 258503 0
Iran, Islamic Republic Of
Primary sponsor type
Shiraz University of medical science, Deputy of research and technology
Shiraz University of medical science-Zand AVe, Fars, IranP.C:71345-1845
Iran, Islamic Republic Of
Secondary sponsor category [1] 257639 0
Name [1] 257639 0
Kamran Bagheri Lankarani
Address [1] 257639 0
Health policy research center,5th floor, Shiraz medical school, Zand Ave, Shiraz, Fars province, Iran.
P.C: 71345-1877
Country [1] 257639 0
Iran, Islamic Republic Of

Ethics approval
Ethics application status
Ethics committee name [1] 260479 0
Local ethical committe of Shiraz University of medical sciences
Ethics committee address [1] 260479 0
Ethics committee country [1] 260479 0
Iran, Islamic Republic Of
Date submitted for ethics approval [1] 260479 0
Approval date [1] 260479 0
Ethics approval number [1] 260479 0

Brief summary
Trial website
Trial related presentations / publications
Public notes

Principal investigator
Name 32215 0
Address 32215 0
Country 32215 0
Phone 32215 0
Fax 32215 0
Email 32215 0
Contact person for public queries
Name 15462 0
Ahad Eshraghian
Address 15462 0
Internal medicine department, Namazi Hospital, Zand Ave, Shiraz, Fars, Iran
P.C 71345-1744
Country 15462 0
Iran, Islamic Republic Of
Phone 15462 0
Fax 15462 0
Email 15462 0
Contact person for scientific queries
Name 6390 0
Kamran B Lankarani
Address 6390 0
Health policy research center, 5th floor, Shiraz University of medical science, Zand Ave, Shiraz, Fars, Iran.
P.C: 71345-1877
Country 6390 0
Iran, Islamic Republic Of
Phone 6390 0
0098 711 230 9615
Fax 6390 0
Email 6390 0

No information has been provided regarding IPD availability
Summary results
No Results